DFTXDefinium Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though heavily shorted (+11% of shares).
Choppy, but holding above its 200-day average. Price is +43% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 20% since the previous count, up from 9.8% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How DFTX is trading
Definium Therapeutics, Inc. is +308% over the past year while the S&P 500 is +18%: 290 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +43%
vs 200-day average · a clear uptrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 22%
Below its 52-week high
Details›
- Last close2026-10-09
- $36.91
- 1 monthS&P 500 +2.7%
- −2.2%
- 1 yearS&P 500 +18%
- +308%
- 5 yearsS&P 500 +88%
- +7.5%
- vs 50-day average$40.34
- −8.5%
- 52-week high
- $47.08
- 52-week low
- $9.54
- Annualised volatility
- 78%
| Year | Return |
|---|---|
| 2026 (year to date) | +176% |
| 2025 | +92% |
| 2024 | +90% |
| 2023 | +66% |
| 2022 | −89% |
| 2021 | −55% |
| 2020 | +5346% |
| 2019 | +27% |
| 2018 | −85% |
| 2017 | −46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +6.4% |
| Feb | 10 | 7 of 10 | +10.0% |
| Mar | 10 | 5 of 10 | +104% |
| Apr | 10 | 6 of 10 | +2.0% |
| May | 10 | 3 of 10 | −3.5% |
| Jun | 10 | 5 of 10 | −0.47% |
| Jul | 10 | 4 of 10 | −2.4% |
| Aug | 10 | 4 of 10 | +35% |
| Sep | 10 | 3 of 10 | −4.2% |
| Oct | 10 | 6 of 10 | +4.2% |
| Nov | 9 | 3 of 9 | +6.8% |
| Dec | 10 | 6 of 10 | +11% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.